Together, these results demonstrate that ablation of FAK or its kinase activity inhibits VEGF-induced EC proliferation and migration, which may lead to the reduced angiogenesis observed in cKO and cKD mice. This evidence concerns the gene PTK2 and chronic kidney disease.